Wellington Partners
WP
Financial Advisors
Wellington Partners
Kensington Pavilion, London W8 4SG
# Wellington Partners
Wellington Partners is a leading European venture capital firm specialising in early-stage and growth-stage life sciences companies. Based in London, the firm has operated since 1998, investing in breakthrough and innovative technologies across therapeutics, medical devices, diagnostics, digital health, and industrial biotechnology. They focus primarily on companies from Germany, Europe and beyond with truly disruptive potential.
The firm serves ambitious entrepreneurs and founders seeking capital, strategic guidance and operational support to scale their life sciences ventures into global leaders. Wellington Partners partners with visionary founders who are tackling significant healthcare challenges and have the potential to transform their sectors.
What distinguishes Wellington Partners is their deeply specialised focus exclusively on life sciences innovation, combined with their extensive track record and highly experienced investment team. Their portfolio demonstrates remarkable exits, IPOs and trade sales, evidencing genuine sector expertise. The firm moves beyond capital provision, actively enabling entrepreneurial vision and unlocking company potential through their network and knowledge. Their recent portfolio achievements—including clinical breakthroughs from companies like Beren Therapeutics (FDA drug application acceptance), Seamless Therapeutics (Lilly collaboration), and Polares Medical (Series C funding)—underscore their ability to support ventures through critical inflection points. This specialisation, longevity since 1998, and demonstrable portfolio success set them apart from generalist venture firms.
Wellington Partners is a leading European venture capital firm specialising in early-stage and growth-stage life sciences companies. Based in London, the firm has operated since 1998, investing in breakthrough and innovative technologies across therapeutics, medical devices, diagnostics, digital health, and industrial biotechnology. They focus primarily on companies from Germany, Europe and beyond with truly disruptive potential.
The firm serves ambitious entrepreneurs and founders seeking capital, strategic guidance and operational support to scale their life sciences ventures into global leaders. Wellington Partners partners with visionary founders who are tackling significant healthcare challenges and have the potential to transform their sectors.
What distinguishes Wellington Partners is their deeply specialised focus exclusively on life sciences innovation, combined with their extensive track record and highly experienced investment team. Their portfolio demonstrates remarkable exits, IPOs and trade sales, evidencing genuine sector expertise. The firm moves beyond capital provision, actively enabling entrepreneurial vision and unlocking company potential through their network and knowledge. Their recent portfolio achievements—including clinical breakthroughs from companies like Beren Therapeutics (FDA drug application acceptance), Seamless Therapeutics (Lilly collaboration), and Polares Medical (Series C funding)—underscore their ability to support ventures through critical inflection points. This specialisation, longevity since 1998, and demonstrable portfolio success set them apart from generalist venture firms.
Services offered
Venture capital investmentearly-stage company fundinggrowth-stage company fundingportfolio company strategic supportlife sciences sector expertiseEuropean expansion supportfundraising consultationexit strategy guidance